Appointment booking for Dr. Anthony Kulczycki, MD is currently not available.Dr. Anthony Kulczycki, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Anthony Kulczycki, MD (he/him) is a Allergist in Saint Louis, MO with over 18 years of experience. What is your opinion of Dr. Anthony Kulczycki, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Anthony Kulczycki, MD has received over $6,021 which includes payments from the following companies:
$2,641.66 from CSL Behring
$695.94 from Genentech USA, Inc.
$493.32 from Teva Pharmaceuticals USA, Inc.
$456.14 from Meda Pharmaceuticals, Inc.
$219.18 from Optinose US, Inc.
$205.20 from Pfizer Inc.
$196.43 from AstraZeneca Pharmaceuticals LP
$193.73 from Merck Sharp & Dohme Corporation
$135.02 from Baxalta US Inc
$125.53 from Novartis Pharmaceuticals Corporation
$122.03 from GlaxoSmithKline, LLC.
$119.53 from Baxter Healthcare
$119.39 from Regeneron Healthcare Solutions, Inc.
$99.63 from Shire North American Group Inc
$95.65 from Kaleo, Inc.
$70.50 from Aerocrine, Inc
$18.77 from Greer Laboratories, Inc.
$13.79 from Sunovion Pharmaceuticals Inc.
Payments received by Dr. Anthony Kulczycki, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!